BIENAIME JEAN JACQUES
22 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-15 | KROS | Keros Therapeutics, Inc. | Buy | 1,000 | $10.61 | $10,610.00 | filing |
| 2026-06-15 | KROS | Keros Therapeutics, Inc. | Buy | 1,000 | $10.19 | $10,190.00 | filing |
| 2026-06-08 | INCY | INCYTE CORP | Award | 1,642 | $0.00 | $0.00 | filing |
| 2026-06-05 | IMNM | Immunome Inc. | Sale | 10,000 | $19.41 | $194,100.00 | filing |
| 2026-06-05 | IMNM | Immunome Inc. | Buy | 6,000 | $19.48 | $116,880.00 | filing |
| 2026-06-05 | IMNM | Immunome Inc. | Buy | 3,500 | $19.46 | $68,110.00 | filing |
| 2026-06-05 | IMNM | Immunome Inc. | Buy | 1,000 | $19.27 | $19,270.00 | filing |
| 2026-06-05 | IMNM | Immunome Inc. | Sale | 500 | $19.44 | $9,720.00 | filing |
| 2026-06-03 | KROS | Keros Therapeutics, Inc. | Award | 7,142 | $0.00 | $0.00 | filing |
| 2026-05-29 | ASND | Ascendis Pharma A/S | Buy | 200 | $223.76 | $44,752.00 | filing |
| 2026-05-29 | ASND | Ascendis Pharma A/S | Buy | 200 | $222.30 | $44,460.00 | filing |
| 2026-05-29 | ASND | Ascendis Pharma A/S | Buy | 100 | $223.50 | $22,350.00 | filing |
| 2026-05-26 | INCY | INCYTE CORP | Tax withholding | 13,059 | $97.10 | $1.3M | filing |
| 2026-05-26 | INCY | INCYTE CORP | Option exercise | 15,000 | $84.53 | $1.3M | filing |
| 2026-05-26 | ASND | Ascendis Pharma A/S | Buy | 200 | $239.37 | $47,873.50 | filing |
| 2026-05-26 | ASND | Ascendis Pharma A/S | Buy | 200 | $236.24 | $47,247.00 | filing |
| 2026-05-15 | IMNM | Immunome Inc. | Buy | 5,000 | $20.70 | $103,500.00 | filing |
| 2026-05-15 | KROS | Keros Therapeutics, Inc. | Buy | 1,000 | $10.58 | $10,580.00 | filing |
| 2026-04-15 | KROS | Keros Therapeutics, Inc. | Buy | 1,000 | $11.70 | $11,700.00 | filing |
| 2026-03-11 | IMNM | Immunome Inc. | Buy | 1,000 | $21.55 | $21,550.00 | filing |
| 2026-03-10 | IMNM | Immunome Inc. | Buy | 1,000 | $22.12 | $22,120.00 | filing |
| 2026-03-09 | KROS | Keros Therapeutics, Inc. | Buy | 2,000 | $11.21 | $22,420.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.